Aziz, Q., Doré, J., Emmanuel, A., Guarner, F., Quigley, E. M. (2013). Gut microbiota and gastrointestinal health: Current concepts and future directions. Neurogastroenterol Motil, 25(1), 4–15.
Google Scholar | Crossref | Medline | ISI Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., Wüllner, U. (2017). Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients. Genome Med, 9(1), 39.
Google Scholar | Crossref | Medline Bercik, P. (2011). The microbiota-gut-brain axis: Learning from intestinal bacteria? Gut, 60(3), 288–289.
Google Scholar | Crossref | Medline | ISI Bhattarai, Y., Si, J., Pu, M., Ross, O., McLean, P., Till, L., Moor, W., Grover, M., Kandimalla, K., Margolis, K., Farrugia, G., Kashyap, P. (2021). Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson’s disease. Gut Microbes, 13(1), 1866974.
Google Scholar | Crossref | Medline Bonaz, B. L., Bernstein, C. N. (2013). Brain-gut interactions in inflammatory bowel disease. Gastroenterology, 144(1), 36–49.
Google Scholar | Crossref | Medline | ISI Cakmak, Y. O. (2015). Provotella-derived hydrogen sulfide, constipation, and neuroprotection in Parkinson’s disease. Mov Disord, 30(8), 1151.
Google Scholar | Crossref | Medline Caso, J. R., Balanzá-Martínez, V., Palomo, T., García-Bueno, B. (2016). The microbiota and gut-brain axis: Contributions to the immunopathogenesis of schizophrenia. Curr Pharm Des, 22(40), 6122–6133.
Google Scholar | Crossref | Medline Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., Cryan, J. F. (2013). The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry, 18(6), 666–673.
Google Scholar | Crossref | Medline | ISI Collins, S. M., Surette, M., Bercik, P. (2012). The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol, 10(11), 735–742.
Google Scholar | Crossref | Medline | ISI Cryan, J. F., Dinan, T. G. (2012). Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci, 13(10), 701–712.
Google Scholar | Crossref | Medline | ISI Cryan, J. F., O'Mahony, S. M. (2011). The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterol Motil, 23(3), 187–192.
Google Scholar | Crossref | Medline | ISI Davari, S., Talaei, S. A., Alaei, H., Salami, M. (2013). Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: Behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience, 240, 287–296.
Google Scholar | Crossref | Medline De Palma, G., Collins, S. M., Bercik, P., Verdu, E. F. (2014). The microbiota-gut-brain axis in gastrointestinal disorders: Stressed bugs, stressed brain or both? J Physiol, 592(14), 2989–2997.
Google Scholar | Crossref | Medline Di, B. S., Drapeau, C., Garcíaalmodóvar, E., Petrosillo, N. (2013). Fecal microbiota transplantation: The state of the art. Infect Dis Rep, 5(2), 451–460.
Google Scholar Dogra, N., Mani, R., Katare, D. (2021). The gut-brain axis: Two ways signaling in Parkinson’s disease. Cell Mol Neurobiol. Advance online publication. https://doi.org/10.1007/s10571-021-01066-7.
Google Scholar | Crossref Eiseman, B., Silen, W., Bascom, G. S., Kauvar, A. J. (1958). Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery, 44(5), 854–859.
Google Scholar | Medline | ISI Felice, V., Quigley, E., Sullivan, A., O'Keeffe, G., O'Mahony, S. (2016). Microbiota-gut-brain signalling in Parkinson’s disease: Implications for non-motor symptoms. Parkinsonism Relat Disord, 27, 1–8.
Google Scholar | Crossref | Medline Foster, J. A., McVey Neufeld, K. A. (2013). Gut-brain axis: How the microbiome influences anxiety and depression. Trends Neurosci, 36(5), 305–312.
Google Scholar | Crossref | Medline | ISI Goswami, P., Joshi, N., Singh, S. (2017). Neurodegenerative signaling factors and mechanisms in Parkinson’s pathology. Toxicol In Vitro, 43, 104–112.
Google Scholar | Crossref | Medline Grenham, S., Clarke, G., Cryan, J. F., Dinan, T. G. (2011). Brain-gut-microbe communication in health and disease. Front Physiol, 2, 94.
Google Scholar | Crossref | Medline | ISI Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., Ohno, K., Hirayama, M. (2015). Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson’s disease. PLoS One, 10(11), e0142164.
Google Scholar | Crossref | Medline Hill-Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P. (2017). Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome. Mov Disord, 32(5), 739–749.
Google Scholar | Crossref | Medline Hopfner, F., Künstner, A., Müller, S. H., Künzel, S., Zeuner, K. E., Margraf, N. G., Deuschl, G., Baines, J. F., Kuhlenbäumer, G. (2017). Gut microbiota in Parkinson disease in a northern German cohort. Brain Res, 1667, 41–45.
Google Scholar | Crossref | Medline Hu, L. F., Lu, M., Tiong, C. X., Dawe, G. S., Hu, G., Bian, J. S. (2010). Neuroprotective effects of hydrogen sulfide on Parkinson’s disease rat models. Aging Cell, 9(2), 135–146.
Google Scholar | Crossref | Medline Iwaki, M., Kessoku, T., Ozaki, A., Kasai, Y., Kobayashi, T., Nogami, A., Honda, Y., Ogawa, Y., Imajo, K., Yoneda, M., Maeda, A., Tanaka, Y., Nakajima, S., Ohno, H., Usuda, H., Kawanaka, M., Kawaguchi, T., Torimura, T., Kage, M., Hyogo, H., . . . Nakajima, A. (2021). Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. Advance online publication. https://doi.org/10.1111/jgh.15487
Google Scholar Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F. (2016). Alterations of the human gut microbiome in multiple sclerosis. Nat Commun, 7, 12015.
Google Scholar | Crossref | Medline | ISI Johnson, M. E., Stringer, A., Bobrovskaya, L. (2018). Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson’s disease. Neurotoxicology, 65, 174–185.
Google Scholar | Crossref | Medline Kang, Y., Cai, Y. (2017a). Gut microbiota and depression: From pathogenesis to new therapeutic strategies. Rev Med Microbiol, 28(2), 56–62.
Google Scholar | Crossref Kang, Y., Cai, Y. (2017b). Gut microbiota and obesity: Implications for fecal microbiota transplantation therapy. Horm-Int J Endocrino, 16(3), 223–234.
Google Scholar Kang, Y., Cai, Y. (2018a). The development of probiotics therapy to obesity: A therapy that has gained considerable momentum. Hormones (Athens, Greece), 17(2), 141–151.
Google Scholar | Crossref | Medline Kang, Y., Cai, Y. (2018b). Future prospect of faecal microbiota transplantation as a potential therapy in asthma. Allergol Immunopath, 46(3), 307–309.
Google Scholar | Crossref | Medline Kang, Y., Cai, Y. (2018c). Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies. Clin Res Hepatol Gas, 42(2), 110–117.
Google Scholar | Crossref | Medline Kang, Y., Cai, Y. (2019a). Altered gut microbiota in HIV infection: Future perspective of fecal microbiota transplantation therapy. AIDS Res Hum Retrov, 35(3), 229–235.
Google Scholar | Crossref | Medline Kang, Y., Li, Y., Du, Y., Guo, L., Chen, M., Huang, X., Yang, F., Hong, J., Kong, X. (2019). Konjaku flour reduces obesity in mice by modulating the composition of the gut microbiota. Int J Obesity, 43(8), 1631–1643.
Google Scholar | Crossref Kang, Y., Cai, Y., Zhang, H. (2017). Gut microbiota and allergy/asthma: From pathogenesis to new therapeutic strategies. Allergol Immunopath, 45(3), 305–309.
Google Scholar | Crossref | Medline Kang, Y., Zhang, X., Cai, Y., Su, J., Kong, X. (2016). Gut microbiota and metabolic disease: From pathogenesis to new therapeutic strategies. Rev Med Microbiol, 27(4), 141–152.
Google Scholar | Crossref Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., Shannon, K. M. (2015). Colonic bacterial composition in Parkinson’s disease. Mov Disord, 30(10), 1351–1360.
Google Scholar | Crossref | Medline Kida, K., Yamada, M., Tokuda, K., Marutani, E., Kakinohana, M., Kaneki, M., Ichinose, F. (2011). Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson’s disease. Antioxid Redox Signal, 15(2), 343–352.
Google Scholar | Crossref | Medline Li, P., Killinger, B., Ensink, E., Beddows, I., Yilmaz, A., Lubben, N., Lamp, J., Schilthuis, M., Vega, I., Woltjer, R., Pospisilik, J., Brundin, P., Brundin, L., Graham, S., Labrie, V. (2021). Gut microbiota dysbiosis is associated with elevated bile acids in Parkinson’s disease. Metabolites, 11(1), 29.
Google Scholar | Crossref | Medline Li, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., Qin, B. (2017). Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features. Sci China Life Sci, 60(11), 1223–1233.
Google Scholar | Crossref | Medline Marques, T. M., Wall, R., Ross, R. P., Fitzgerald, G. F., Ryan, C. A., Stanton, C. (2010). Programming infant gut microbiota: Influence of dietary and environmental factors. Curr Opin Biotechnol, 21(2), 149–156.
Google Scholar | Crossref | Medline Martinez-Martin, P. (2011). The importance of non-motor disturbances to quality of life in Parkinson’s disease. J Neurol Sci, 310(1–2), 12–16.
Google Scholar | Crossref | Medline Mayer, E. A. (2011). Gut feelings: The emerging biology of gut-brain communication. Nat Rev Neurosci, 12(8), 453–466.
Google Scholar | Crossref | Medline | ISI Mayer, E. A., Knight, R., Mazmanian, S. K., Cryan, J. F. (2014). Gut microbes and the brain: Paradigm shift in neuroscience. J Neurosci, 34(46), 15490–15496.
Google Scholar Mayer, E. A., Tillisch, K., Bradesi, S. (2006). Review article: Modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther, 24(6), 919–933.
Google Scholar | Crossref | Medline O'Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., Cryan, J. F. (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res, 277, 32–48.
Google Scholar | Crossref | Medline | ISI O'Mahony, S. M., Hyland, N. P., Dinan, T. G., Cryan, J. F. (2011). Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology (Berl), 214(1), 71–88.
Google Scholar | Crossref | Medline Parashar, A., Udayabanu, M. (2017). Gut microbiota: Implications in Parkinson’s disease. Parkinsonism Relat Disord, 38, 1–7.
Google Scholar | Crossref |